Françoise Bono
Corporate Officer/Principal chez OSE IMMUNOTHERAPEUTICS
Profil
Françoise Bono is currently the Senior Director-Strategic Development at OSE Immunotherapeutics SA since 2021.
Prior to this, she worked as the Chief Scientific Officer at Valerio Therapeutics SA from 2017 to 2020 and as the Executive Vice President-Oncology at Evotec (France) SAS from 2015 to 2016.
Dr. Bono holds a doctorate degree from Institut d'Administration Des Entreprises De Toulouse.
Postes actifs de Françoise Bono
| Sociétés | Poste | Début |
|---|---|---|
| OSE IMMUNOTHERAPEUTICS | Corporate Officer/Principal | 20/12/2021 |
Anciens postes connus de Françoise Bono
| Sociétés | Poste | Fin |
|---|---|---|
| VALERIO THERAPEUTICS | Chief Tech/Sci/R&D Officer | 01/11/2020 |
Evotec (France) SAS
 Evotec (France) SAS Miscellaneous Commercial ServicesCommercial Services Part of Evotec SE, Evotec (France) SAS is a French company that engages in research and development of physical and natural sciences. The private company is based in Toulouse, France. The company was founded in 2014. Pierre Cooremans has been the CEO of the company since 2019. | Corporate Officer/Principal | 01/11/2016 |
Formation de Françoise Bono
| Institut d'Administration Des Entreprises De Toulouse | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| VALERIO THERAPEUTICS | Health Technology |
| OSE IMMUNOTHERAPEUTICS | Health Technology |
| Entreprise privées | 1 |
|---|---|
Evotec (France) SAS
Evotec (France) SAS Miscellaneous Commercial ServicesCommercial Services Part of Evotec SE, Evotec (France) SAS is a French company that engages in research and development of physical and natural sciences. The private company is based in Toulouse, France. The company was founded in 2014. Pierre Cooremans has been the CEO of the company since 2019. | Commercial Services |
